Zhensheng Huang

Title: Innovations by Zhensheng Huang in Pharmaceutical Development

Introduction

Zhensheng Huang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target CRTH2 receptors. His work has led to the filing of two patents that showcase his innovative approach to treating diseases related to these receptors.

Latest Patents

Huang's latest patents include a tricyclic compound as a CRTH2 inhibitor. This patent describes a tricyclic compound, or its pharmaceutically acceptable salt, tautomer, stereoisomer, or solvate, that is used in treating diseases associated with CRTH2 receptors. Another significant patent is for an indole derivative used as a CRTH2 inhibitor. This application discloses an indole, along with its pharmaceutically acceptable salt or tautomer, and its application in treating diseases related to CRTH2 receptors.

Career Highlights

Zhensheng Huang is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this company has allowed him to focus on innovative pharmaceutical solutions that address critical health issues. His expertise in medicinal chemistry and pharmacology has been instrumental in advancing the company's research initiatives.

Collaborations

Huang collaborates with several talented individuals in his field, including Bin Chen and Yuanshan Yao. These collaborations enhance the research and development efforts at Chia Tai Tianqing Pharmaceutical Group Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Zhensheng Huang's contributions to pharmaceutical innovation, particularly in the area of CRTH2 inhibitors, highlight his role as a leading inventor in the industry. His patents reflect a commitment to advancing medical science and improving patient outcomes.